{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:12:47Z","timestamp":1784769167826,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.autrev.2020.102462","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T06:13:23Z","timestamp":1578377603000},"page":"102462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: An Immunopathogenic perspective"],"prefix":"10.1016","volume":"19","author":[{"given":"Anna","family":"Tarasidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccm.2015.08.001","article-title":"The etiologic role of infectious antigens in sarcoidosis pathogenesis","volume":"36","author":"Celada","year":"2015","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.autrev.2020.102462_bb0010","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/CVI.05118-11","article-title":"Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102462_bb0015","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102462_bb0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fimmu.2018.01113","article-title":"Comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance","volume":"9","author":"Martinez-Prat","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102462_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic Sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One"},{"issue":"Supplement_6","key":"10.1016\/j.autrev.2020.102462_bb0030","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1513\/AnnalsATS.201707-565OT","article-title":"Genetic, immunologic, and environmental basis of sarcoidosis","volume":"14","author":"Moller","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","article-title":"Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in Sarcoidosis","volume":"29","author":"Wik\u00e9n","year":"2009","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humimm.2018.05.007","article-title":"A sarcoidosis clinician\u2019s perspective of MHC functional elements outside the antigen binding site","volume":"80","author":"Judson","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2020.102462_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/ajrccm.152.2.7633707","article-title":"\u201cThe sarcoidosis map\u201d: a joint survey of clinical and immunogenetic findings in two European countries","volume":"152","author":"Martinetti","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102462_bb0050","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.156.5.9704069","article-title":"HLA-DR predicts the prognosis in scandinavian patients with pulmonary sarcoidosis","volume":"156","author":"Berlin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2017.10.018","article-title":"Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)","volume":"17","author":"Grumet","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102462_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.autrev.2017.03.006","article-title":"Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300 patients","volume":"16","author":"Hadjadj","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid a regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of Sarcoidosis granulomas reveals antimicrobial targets","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am J Resp Cell Mol Biol (Online)"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.iac.2012.08.005","volume":"32","author":"Culver","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9","key":"10.1016\/j.autrev.2020.102462_bb0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2020.102462_bb0085","first-page":"197","article-title":"Sarcoidosis and autoimmunity: from genetic background to environmental factors","volume":"18","author":"Bindoli","year":"2016","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170285","article-title":"Proteomic analysis of Kveim reagent identifies targets of cellular immunity in sarcoidosis","volume":"12","author":"Eberhardt","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2020.102462_bb0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/meth.1996.0033","article-title":"Sarcoidosis: a model of granulomatous inflammation of unknown etiology associated with a hyperactive immune system","volume":"9","author":"Kataria","year":"1996","journal-title":"Methods."},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/imt.14.103","article-title":"Targeting CD4","volume":"7","author":"Celada","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102462_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CVI.00469-10","article-title":"Low levels of NF-B\/p65 mark Anergic CD4+ T cells and correlate with disease severity in sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102462_bb0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4+T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2016-0037OC","article-title":"Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signaling impairs Sarcoidosis CD4+T cell proliferation","volume":"56","author":"Celada","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102462_bb0125","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Oswald-Richter","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102462_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2017.10.006","article-title":"Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-L\u00f6fgren\u2019s disease","volume":"138","author":"Parasa","year":"2018","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0135","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000132","article-title":"Patients with chronic sarcoidosis have reduced CD27+IgM+IgD+ unswitched memory B cells and an expanded population of terminal effector CD8+CD27-CD28- T cells","volume":"3","author":"Heaps","year":"2012","journal-title":"J Clin Cell Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102462_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/01902140303786","article-title":"Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis","volume":"29","author":"Oltmanns","year":"2003","journal-title":"Exp Lung Res"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2020.102462_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.20452\/pamw.1341","article-title":"Th1\/Th2\/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking","volume":"122","author":"Urbankowski","year":"2012","journal-title":"Pol Arch Med Wewn"},{"issue":"2","key":"10.1016\/j.autrev.2020.102462_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1189\/jlb.1202628","article-title":"High expression of p21Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation","volume":"74","author":"Xaus","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","article-title":"TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis","volume":"67","author":"Nguyen","year":"2018","journal-title":"Allergol Int"},{"issue":"11","key":"10.1016\/j.autrev.2020.102462_bb0160","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201512-2419ED","article-title":"Sarcoidosis and T-helper cells. Th1, Th17, or Th17.1?","volume":"193","author":"Georas","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102462_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10875-012-9817-6","article-title":"Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-\u03b3 expression","volume":"33","author":"Richmond","year":"2013","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0170","first-page":"334","article-title":"The roles of T helper 1, T helper 17 and regulatory T cells in the pathogenesis of sarcoidosis","volume":"15","author":"Mortaz","year":"2016","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102462_bb0175","article-title":"Immunopathogenesis of granulomas in chronic autoinflammatory diseases","volume":"5","author":"WMC","year":"2016","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The formation and function of granulomas","volume":"36","author":"Pag\u00e1n","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102462_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40425-018-0372-4","article-title":"Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment","volume":"6","author":"Paolini","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102462_bb0205","first-page":"2","article-title":"Scadding revisited: a proposed staging system for cardiac sarcoidosis","volume":"31","author":"Berman","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102462_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/ced.12793","article-title":"Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?","volume":"41","author":"Galimberti","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102462_bb0215","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:39Z","timestamp":1761599859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220300057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1568997220300057"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102462","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: An Immunopathogenic perspective","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102462"}}